XML 24 R33.htm IDEA: XBRL DOCUMENT v2.4.1.9
Shareholders' Equity (Tables)
12 Months Ended
Dec. 31, 2014
Shareholders' Equity [Abstract]  
Schedule of assumptions used in estimation of grant date fair value of options


2. The Company recognizes compensation expenses on these options based on estimated grant date fair value using the Binomial option-pricing model with the following assumptions:

 




Average Risk-free interest rate (a)

1.33 %




Expected dividend yield

0.0 %




Average expected volatility (b)

64.71 %




Termination rate

9 %




Suboptimal rate (c)

3.2





(a)

Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.




(b)

Expected average volatility represents a weighted average standard deviation rate for the price of the Company's ordinary shares on the NASDAQ National Market.




(c)

Suboptimal rate represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal rate of the Company and similar companies.
Schedule of assumptions used in estimation of grant date fair value of RSUs


3. The Company recognizes compensation expenses on these RSUs based on estimated grant date fair value, with the following assumptions:

 




Expected dividend yield

2.06%




Termination rate

4.35%


Stock Option Summary

F. The following table summarizes information regarding stock options as at December 31, 2014:

 

    

Options outstanding

 

Options exercisable

        

Weighted average

     

Weighted average

        

remaining

     

remaining

Exercise price

 

Number

 

contractual life

 

Number

 

contractual life

US$

 

of options

 

(in years)

 

of options

 

(in years)

                    

15.28

 

192,130

 

5.7

 

78,130

 

5.7

Summary of information regarding Restricted Share Units

G. The following table summarizes information regarding Restricted Share Units as at December 31, 2014:

 







Restricted

Vested

 


 

 

 

 

 

Share Units



Restricted

 


 

 

 

 

 

Outstanding



Share Units









 

 

 

 

 

 

 

 

74,000



 -


Stock Option Activity

H. The stock option activity under the abovementioned plans is as follows: 

 

                     

Weighted

               

Weighted

   

average

         

Number

   

average

   

grant date

         

of options

   

exercise price

   

fair value

               

US$

   

US$

                     

Balance at January 1, 2012

      257,425        
               

Granted

      240,000     15.28     6.54

Exercised

      (82,338)     3.35     1.81

Forfeited

      (2,000)     15.28     6.54
               

Balance at December 31, 2012

      413,087        
               

Exercised

      (132,587)     14.28     6.61

Forfeited

      (7,750   15.28     6.54
               

Balance at December 31, 2013

      272,750        
               

Exercised

      (78,620)     17.19     7.70

Forfeited

      (2,000)     15.28     6.54
               

Balance at December 31, 2014

      192,130        

Exercisable at December 31, 2014

      78,130        
Schedule of Restricted Share Units activity

I. The Restricted Share Units activity under the abovementioned plans is as follows:

 

               

Weighted

           

Number of

   

average

           

Restricted

   

grant date

           

Share Units

   

fair value

            US$     US$

Balance at January 1, 2014

          -    

Granted

          74,000     46.07

Balance at December 31, 2014

          74,000    
Summary of Allocation of the Stock-Based Compensation Expenses

J. During 2012, 2013 and 2014, the Company recorded share-based compensation expenses. The following summarizes the allocation of the stock-based compensation expenses:

 

       

Year ended December 31

       

2012

 

2013

 

2014

       

US$ thousands

 

US$ thousands

 

US$ thousands

                 
   

Cost of sales

 

46

 

103

 

124

   

Research and development costs

 

130

 

193

 

340

   

Selling and marketing expenses

 

159

 

177

 

366

   

General and administrative expenses

 

209

 

195

 

436

       

544

 

668

 

1,266